当前位置： SCI文献检索 > BMC GENOMICS期刊下所有文献 > Alternative splicing enriched cDNA libraries identify breast cancer-associated transcripts.

Alternative splicing enriched cDNA libraries identify breast cancer-associated transcripts.

Abstract：

BACKGROUND:Alternative splicing (AS) is a central mechanism in the generation of genomic complexity and is a major contributor to transcriptome and proteome diversity. Alterations of the splicing process can lead to deregulation of crucial cellular processes and have been associated with a large spectrum of human diseases. Cancer-associated transcripts are potential molecular markers and may contribute to the development of more accurate diagnostic and prognostic methods and also serve as therapeutic targets. Alternative splicing-enriched cDNA libraries have been used to explore the variability generated by alternative splicing. In this study, by combining the use of trapping heteroduplexes and RNA amplification, we developed a powerful approach that enables transcriptome-wide exploration of the AS repertoire for identifying AS variants associated with breast tumor cells modulated by ERBB2 (HER-2/neu) oncogene expression. RESULTS:The human breast cell line (C5.2) and a pool of 5 ERBB2 over-expressing breast tumor samples were used independently for the construction of two AS-enriched libraries. In total, 2,048 partial cDNA sequences were obtained, revealing 214 alternative splicing sequence-enriched tags (ASSETs). A subset with 79 multiple exon ASSETs was compared to public databases and reported 138 different AS events. A high success rate of RT-PCR validation (94.5%) was obtained, and 2 novel AS events were identified. The influence of ERBB2-mediated expression on AS regulation was evaluated by capillary electrophoresis and probe-ligation approaches in two mammary cell lines (Hb4a and C5.2) expressing different levels of ERBB2. The relative expression balance between AS variants from 3 genes was differentially modulated by ERBB2 in this model system. CONCLUSIONS:In this study, we presented a method for exploring AS from any RNA source in a transcriptome-wide format, which can be directly easily adapted to next generation sequencers. We identified AS transcripts that were differently modulated by ERBB2-mediated expression and that can be tested as molecular markers for breast cancer. Such a methodology will be useful for completely deciphering the cancer cell transcriptome diversity resulting from AS and for finding more precise molecular markers.

journal_name

BMC Genomics

journal_title

BMC genomics

authors

Ferreira EN,Rangel MC,Galante PF,de Souza JE,Molina GC,de Souza SJ,Carraro DM

doi

10.1186/1471-2164-11-S5-S4

subject

Has Abstract

pub_date

2010-12-22 00:00:00

pages

issn

1471-2164

pii

1471-2164-11-S5-S4

journal_volume

11 Suppl 5

pub_type

杂志文章

在线工具

Alternative splicing enriched cDNA libraries identify breast cancer-associated transcripts.